Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Buy
+1,429
New +$207K ﹤0.01% 846
2022
Q3
Sell
-10,952
Closed -$1.33M 1046
2022
Q2
$1.33M Hold
10,952
0.01% 930
2022
Q1
$1.56M Hold
10,952
0.01% 899
2021
Q4
$1.93M Sell
10,952
-1,171
-10% -$196K 0.01% 869
2021
Q3
$1.87M Buy
12,123
+2,417
+25% +$351K 0.01% 760
2021
Q2
$1.31M Sell
9,706
-9,234
-49% -$1.24M 0.01% 791
2021
Q1
$2.5M Buy
18,940
+153
+0.8% +$20.1K 0.01% 672
2020
Q4
$2.22M Hold
18,787
0.01% 666
2020
Q3
$1.98M Hold
18,787
0.01% 783
2020
Q2
$2.01M Sell
18,787
-10,259
-35% -$953K 0.01% 762
2020
Q1
$2.32M Hold
29,046
0.02% 701
2019
Q4
$2.57M Hold
29,046
0.02% 613
2019
Q3
$2.37M Hold
29,046
0.02% 608
2019
Q2
$2.74M Buy
+29,046
New +$2.48M 0.02% 599

Other funds holding NOVT

Aviva's NOVT Position: Q2 2026 in Review

Aviva opened a new position in Novanta (NOVT) in Q2 2026: 1,429 shares worth $232K. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings. This is a return to the name: Aviva previously reported a position in NOVT as recently as Q2 2022.

Aviva first reported a position in NOVT in Q2 2019 and has held it in 14 quarters since. The position peaked at $2.74M in Q2 2019. 390 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Aviva held 1,429 shares of Novanta worth $232K as of Q2 2026.
  • Novanta was a new Aviva position in Q2 2026.
  • Novanta made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #846 holding.
  • Aviva first reported a position in Novanta in Q2 2019 and has held it in 14 quarters since.
  • Aviva's Novanta position peaked at $2.74M in Q2 2019.
  • 390 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.